Increasing prevalence of diabetes and the rising geriatric population is expected to boost the growth of the global continuous glucose monitoring device market at a CAGR of 11.24% during the forecast period 2024 to 2032

Market Research Future (MRFR) has published on the “Global Continuous Glucose Monitoring System Market”.

Market Research Future (MRFR) has published a cooked research report on the “global continuous glucose monitoring device market” that contains the information from 2019 to 2032. The continuous glucose monitoring device market is estimated to register a CAGR of 11.24% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global continuous glucose monitoring device market— Dexcom, Inc (US) , A. Menarini Diagnostics Srl (Italy), Senseonics  (US), Medtrum Technologies Inc.  (China), Nemaura Medical Inc (US), Ultrahuman Healthcare Pvt Ltd (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), Sinocare (China)

Market Highlights

The global continuous glucose monitoring device market is accounted to register a CAGR of 11.24% during the forecast period and is estimated to reach USD 25.81 billion by 2032.

Continuous glucose monitoring devices are essential for giving patients and medical professionals access to real-time information about blood glucose levels. The Continuous glucose monitoring device  market  was evaluated at  8.90 billion in 2023.North-America held the largest market share of 34.86% followed by Europe at  28.94%.

The growing incidence of diabetes, growing public awareness, and an aging population are expected to fuel growth in the worldwide market for continuous glucose monitoring systems. According to the International Diabetes Federation (IDF), in 2021, approximately 537 million people worldwide were living with diabetes, and this number is expected to soar to 643 million by 2030. Similarly, according to the American Diabetes Association, diabetes affected 38.4 million Americans, or 11.6% of the population, in 2021. Type 1 diabetes affects around 2.0 million Americans, including approximately 304,000 children and adolescents

Additionally, the market will have development prospects in the future due to the expanding innovation and technical advancements.

Access full report @ https://www.marketresearchfuture.com/reports/continuous-glucose-monitoring-system-market-20310

Segment Analysis

The global continuous glucose monitoring device market has been segmented based on product, application, and end user.

On the basis of the product, the market is segmented into sensors and transmitter and receivers. The Sensor segment held the largest market share in 2023. A sensor is a small, disposable device inserted under the skin that uses a tiny electrode to measure glucose levels in the interstitial fluid. The sensor continuously detects glucose levels and sends the data to a receiver or smartphone. CGM sensors estimate the glucose level in the fluid between the cells. Additionally, the sensors in CGM also measure the dynamic changes in blood glucose levels for a diabetic  patients

Based on application, the global continuous glucose monitoring device market has been segmented into type 2 diabetes, type 1 diabetes, non-diabetic patients. The type 1 diabetes market held the largest market share in 2023.

On the basis of the end-user, the market is segmented into hospitals & clinics, homecare settings, and others. The home care segment held the largest market share during the forecast period owing to the rapidly expanding continuous glucose monitoring market due to the increase in diabetes worldwide.

Regional Analysis

The global continuous glucose monitoring device market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe continuous glucose monitoring device market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The continuous glucose monitoring device market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World continuous glucose monitoring device market comprises of Middle East, Africa, and Latin America.

Technological advancements and a rising prevalence of diabetes in the region led to an increase in demand for continuous glucose monitoring devices in North America.

Moreover, factors such as the high number of market competitors in the area, as well as well-developed healthcare infrastructure that supports extensive clinical studies, possibly leading to the growth of the continuous glucose monitoring device industry across the European region.

Additionally, the increasing R&D investments and rising technological advancements are the major factors driving market growth in the Asia-Pacific region.

Furthermore, the rest of the world included the Middle East, Africa, and Latin America. The region accounted for the lowest market share in the continuous glucose monitoring device market. This is due to the presence of poorer economies that lack effective healthcare infrastructure, and lower healthcare spending.

Key Findings of the Study

• The global continuous glucose monitoring device market is expected to reach USD 25.81 billion by 2032, at a CAGR of 11.24% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market, owing to the increasing R&D investments and rising technological advancements.


• Based on application, the type 1 diabetes segment was attributed to holding the largest market in 2023.


• Dexcom, Inc (US), A. Menarini Diagnostics Srl (Italy), Senseonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc (US) are the key market players.